Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
to: J. Andrew Orr-Skirvin, PharmD, BCOP Clinical Professor, Department of Pharmacy & Health Systems Sciences Pharmaceutical Industry Fellowship Program Director 360 Huntington Ave, 140 The Fenway R218
-
biotechnology, nanomedicine, immunology, health informatics, and drug discovery · Network with local residents and other Northeastern fellows via professional development programs, teaching seminars, and
-
of Pharmacy & Health Systems Sciences Pharmaceutical Industry Fellowship Program Director 360 Huntington Ave, 140 The Fenway R218 Boston, MA 02115 Northeastern University will not provide H-1B, TN, O-1, E-3
-
and letters of recommendation to: J. Andrew Orr-Skirvin, PharmD, BCOP Clinical Professor, Department of Pharmacy & Health Systems Sciences Pharmaceutical Industry Fellowship Program Director 360
-
-Skirvin, PharmD, BCOP Clinical Professor, Department of Pharmacy & Health Systems Sciences Pharmaceutical Industry Fellowship Program Director 360 Huntington Ave, 140 The Fenway R218 Boston, MA 02115
-
, BCOP Clinical Professor, Department of Pharmacy & Health Systems Sciences Pharmaceutical Industry Fellowship Program Director 360 Huntington Ave, 140 The Fenway R218 Boston, MA 02115 Northeastern
-
letters of recommendation to: J. Andrew Orr-Skirvin, PharmD, BCOP Clinical Professor, Department of Pharmacy & Health Systems Sciences Pharmaceutical Industry Fellowship Program Director 360 Huntington Ave
-
for program participation. ORISE Information: This program, administered by ORAU through its contract with the U.S. Department of Energy (DOE) to manage the Oak Ridge Institute for Science and Education (ORISE
-
) to manage the Oak Ridge Institute for Science and Education (ORISE), was established through an interagency agreement between DOE and CDC. Participants do not become employees of CDC, DOE or the program
-
in the scientific field of Biological Sciences, enrolled in a doctoral degree programme. I.II - Ineligible candidates: Candidates who have already benefited from two research grant contracts with UC in